Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 19 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research

Synthetic Chemistry

Medicinal Chemistry

Analytical Chemistry

Full Time Equivalent(FTE)

Fee For Service(FFS)

Catalyst Screening

Enzyme Catalysis

Continuous Flow Chemical Technology

Biology Research

Structural Biology

Cell Biology

Enzymology & Molecular Interactions

Antibody Discovery

Translational Medicine

High Throughput Screening

Computational Biology & Molecular Modeling

Early Pharmacokinetics

Radiolabel ADME

02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients

Route Selection

Production Process Optimization

Clinical Sample Production

Impurity Traceability & Control

Generic Drug Process Study & Filing

Innovative Drug Process Study & Filing

Pharmaceutical preparation

Consistency Evaluation

Preformulation Study

Formulation Stability Study

GMP-based Clinical Sample Production & Packaging

Pilot-scale Preparation Testing

Laboratory-scale Preparation Testing

Preparation Quality Research

Formulation Technology Research

Analytical Method Development and Quality Control
CMC Filings
03 Preclinical Research
Pharmacology & Pharmacodynamics

Tumor Models

Digestive System Disease Models

Endocrine & Metabolic Disease Models

Inflammatory & Immune Diseases Models

Neural System Disease Models

Other Disease Models

PDXO Models

Ocular Diseases Models

Cardiovascular Model

Drug Safety Evaluation

Pharmacology & Toxicology Study

Safety Pharmacology

Histopathological Study

Clinicopathological Study

Drug Safety Evaluation Basic Information

Toxicokinetics

DMPK

In Vitro ADME Assays

In Vivo Pharmacokinetic Assays

Bioanalysis

Macromolecular Drugs Bioanalysis

Micromolecular Drugs Bioanalysis

IND Filings
01 One-stop Integrated Services
Drug Discovery Platform
Pharmaceutical Research Platform
Preclinical Research Services
Chemical Drug Development
One-stop API Process R&D Department
CDMO Service Platform
Pharmaceutical Research CDMO Service Platform
Translational Medicine Platform
Botanical Drug Preclinical R&D Technology Platform
02 Innovative Drug Services
ADC R&D Service Platform
PROTAC R&D Service Platform
mRNA Vaccine Bioanalysis Platform
Non-clinical Research for Cellular Immunotherapies
Nucleic Acid Drug R&D Platform
Peptide Drug Conjugate (PDC) R&D Service Platform
Antibody R&D Service
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Platform
Metabolite Identification (MetID) Service Platform
Drug Forming Research Platform
Safety Assessment Lab of Process Chemistry
Flow Cytometry Technology Platform
SEND Format Conversion Platform
Process Department Solid Form Screening Platform
Green Chemistry Platform
Flow Sorting Platform
NanoString nCounter Detection Platform
Routes of Drug Administration Platform
Drug Solid-State Research Service Platform
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model Evaluation Platform
Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease Drug Efficacy Evaluation System
05 Advanced Preparation R&D
Inhalation drug R&D platform
Ophthalmic drug R&D platform
Skin Topical Preparation R&D Platform
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
07 Drug analysis platform
08 Public Services
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 50 Soldiers Field Place, Boston, MA 02135 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2023-10-25Medicilon Events
Medicilon congratulated AnDiCon Biotech collaborated with Simcere Pharmaceuticals to accelerate the commercialization of a new generation of anti-influenza drug ADC189
On October 10, 2023, Simcere Pharmaceutical Group Ltd. (2096.HK) announced that they entered into a collaboration agreement with Jiaxing AnDiCon Biotech Co., Ltd. (AnDiCon) on the anti-influenza innovative drug ADC189.
Learn more
2023-09-20Medicilon Events
Medicilon's Interview: See how Dr. Chen Chen from ABM Therapeutics crosses the blood-brain barrier
Shanghai Medicilon Inc. (Medicilon) has the honor to invite Dr. Chen Chen, Founder and Chairman of ABM Therapeutics, to discuss the unique technical advantages and R&D strategies of ABM Therapeutics in developing brain-targeted drugs, as well as the inner journey and profound insights.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CAREERS
Talent Development
Employee Activities
Campus Recruitment
Social Recruitment
Campus Recruitment
Campus Recruitment
Social Recruitment
Social Recruitment
Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon FTE services & FFS services - flexible and efficient cooperation model| Medicilon appeared at the 25th SAPA-NE Annual Conference
Apr 01,2020
Medicilon CMC-Formulation Department
In 2019, Medicilon has had an extraordinary year. The steadily developing Medicilon made a huge accumulation in 2019 and achieved a qualitative leap.  Let us
More
Medicilon CMC-Formulation Department
Mar 11,2020
Medicilon Drug Discovery - Chemistry Department
The Medicilon Chemistry Department is a professional, efficient, and well-qualified R&D team. The team has more than 40% of employees with a master's degree, doctor's degree, or above.
More
Medicilon Drug Discovery - Chemistry Department
Mar 10,2020
API Process Development of the New Drug IND Stage
In the development of innovative drugs, the progress of the process development of the IND phase of the API often directly affects the subsequent formulation
More
API Process Development of the New Drug IND Stage
Feb 02,2020
Taking the Responsibility and Praying for the Peace; Medicilon helps to fight the coronavirus by providing funds and technology
During the Spring Festival, China has been facing a difficult time as the coronavirus spread all over the country.  In order to stop the coronavirus,
More
Taking the Responsibility and Praying for the Peace; Medicilon helps to fight the coronavirus by providing funds and technology
Dec 27,2019
Medicilon Assists Neupharma's RX108 to Enter Phase I Clinical Trials
​Recently, Suzhou Neupharma, an important partner of Shanghai Medicilon, announced that RX208 China phase I clinical research has completed the administration of the first patient in Shanghai Dongfang Hispital.
More
Medicilon Assists Neupharma's RX108 to Enter Phase I Clinical Trials
Dec 24,2019
Warmest Holiday Season Greeting From Medicilon 2020
Warmest Holiday Greetings to you and your families from Medicilon! As the end of year is approaching, we would like to express our sincere gratitude
More
Warmest Holiday Season Greeting From Medicilon 2020
Dec 19,2019
Medicilon assists Cgenetech to accelerate the development of new anti-diabetic drugs
On December 7, 2019, the 2019 annual meeting of the Biomedical Branch of the Shanghai European and American Alumni Association was held in Shanghai Pudong
More
Medicilon assists Cgenetech to accelerate the development of new anti-diabetic drugs
Dec 10,2019
Medicilon Co-organizes Shanghai European and American Alumni Association's Biomedicine Year-end Meeting
Recently, Medicilon's CMC preparations have developed another success. Amlodipine besylate tablets, a cardiovascular drug 289 base drug project developed for customers for lowering blood pressure,
More
Medicilon Co-organizes Shanghai European and American Alumni Association's Biomedicine Year-end Meeting
Nov 27,2019
Happy Thanksgiving 2019
Medicilon wishes you and your family a Happy Thanksgiving Day!
More
Happy Thanksgiving 2019
Nov 06,2019
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China On Nov. 5th 2019, Shanghai Medicilon Inc. (Medicilon) announced an IPO on
More
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China
Oct 29,2019
Insulin Technology Achieves a New Breakthrough, Medicilon Helps to Make a New Leap Forward!
Medicilon has currently completed the pharmacokinetic study of common insulin and oral insulin compound preparations of a company in Jiangsu, administered the test product subcutaneously and orally, and measured the blood glucose level of animals with a Roche blood glucose meter;
More
Insulin Technology Achieves a New Breakthrough, Medicilon Helps to Make a New Leap Forward!
Sep 27,2019
Medicilon will participate in SAPA-NJ Annual Conference 2019
sapa national conference 2019 SAPA-NJ Annual Conference will take place in Somerset, NJ on Sept 27-28, 2019.  Sino-American Pharmaceutical Professionals Association (SAPA) , founded in 1993,
More
Medicilon will participate in SAPA-NJ Annual Conference 2019
Stock Code
688202

Global

Address: 50 Soldiers Field Place, Boston, MA 02135 (America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->